PYC Therapeutics is an Australian biotechnology company that designs and develops a new class of RNA medicines intended to treat genetic diseases. Its work centres on a delivery technology that carries therapeutic molecules into cells, with early programmes focused on inherited eye conditions that cause vision loss. The company carries out its research and development from its base in Perth, Western Australia, and works on treatments aimed at patients with serious genetic disorders.
PYC Therapeutics Ltd trades under the code PYC on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #62 of 1816 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendStrong
81/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average7.5%
From 52-week high-37.8%
MomentumStrong
91/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return12.8%
6-month return40.9%
12-month, skipping last month136.9%
Stability (higher is calmer)Strong
71/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)54.3%
Worst drawdown, 1 year (smaller is calmer)-38.8%
LiquidityStrong
92/100
Trades actively.
See the numbers →
Avg daily value traded9.42M AUD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 1.045 – 2.930Daily closes, split-adjusted
Signals
50-day average2.344
200-day average1.683
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.141
Technical summary
Daily
Bearish
5 bullish · 1 neutral · 10 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
1.99
Bearish
EMA 10
1.98
Bearish
SMA 20
2.31
Bearish
EMA 20
2.17
Bearish
SMA 50
2.34
Bearish
EMA 50
2.22
Bearish
SMA 100
1.98
Bearish
EMA 100
2.05
Bearish
SMA 200
1.68
Bullish
EMA 200
1.80
Bullish
Oscillators (daily)
RSI (14)
31.51
Neutral
MACD (12, 26)
-0.18
Bearish
Momentum (12)
-32.46
Bearish
Stochastic %K (14)
7.54
Bullish
Williams %R (14)
-92.46
Bullish
CCI (20)
-102.5
Bullish
Pivot points (classic, last session)
S3
1.70
S2
1.73
S1
1.77
Pivot
1.80
R1
1.84
R2
1.87
R3
1.91
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
